IQGAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.493200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.583000E-01
Normal-vs-Stage2
8.132800E-01
Normal-vs-Stage3
1.690030E-01
Normal-vs-Stage4
6.687000E-01
Stage1-vs-Stage2
9.541400E-01
Stage1-vs-Stage3
1.463950E-01
Stage1-vs-Stage4
4.544400E-01
Stage2-vs-Stage3
1.705570E-01
Stage2-vs-Stage4
2.683200E-01
Stage3-vs-Stage4
1.297600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.139200E-01
Normal-vs-AfricanAmerican
6.349000E-01
Normal-vs-Asian
7.005200E-01
Caucasian-vs-AfricanAmerican
1.592010E-01
Caucasian-vs-Asian
9.624200E-01
AfricanAmerican-vs-Asian
2.364200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.999000E-01
Normal-vs-Female
6.815200E-01
Male-vs-Female
6.441400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.995400E-01
Normal-vs-Age(41-60Yrs)
7.216200E-01
Normal-vs-Age(61-80Yrs)
7.415200E-01
Normal-vs-Age(81-100Yrs)
8.741400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.210600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.408400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.736800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.681800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.050000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.208800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.016600E-01
Normal-vs-Daily Drinker
5.816200E-01
Normal-vs-Weekly Drinker
8.554600E-01
Normal-vs-Occasional Drinker
5.679200E-01
Normal-vs-Social Drinker
5.136000E-01
Non Drinker-vs-Daily Drinker
6.343400E-01
Non Drinker-vs-Weekly Drinker
8.252000E-01
Non Drinker-vs-Occasional Drinker
6.120600E-01
Non Drinker-vs-Social Drinker
7.057600E-01
Daily Drinker-vs-Weekly Drinker
6.109200E-01
Daily Drinker-vs-Occasional Drinker
9.715400E-01
Daily Drinker-vs-Social Drinker
9.244400E-01
Weekly Drinker-vs-Occasional Drinker
6.076200E-01
Weekly Drinker-vs-Social Drinker
6.717800E-01
Occasional Drinker-vs-Social Drinker
8.963400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.256600E-01
Normal-vs-Grade 2
6.816300E-02
Normal-vs-Grade 3
1.244820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.281000E-01
Grade 1-vs-Grade 3
4.674200E-01
Grade 1-vs-Grade 4
2.256600E-01
Grade 2-vs-Grade 3
9.347800E-01
Grade 2-vs-Grade 4
6.816300E-02
Grade 3-vs-Grade 4
1.244820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.373000E-01
Normal-vs-NonDiabetic
6.205400E-01
Diabetic-vs-NonDiabetic
7.736600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.664000E-02
Normal-vs-NoPancreatitis
7.398400E-01
Pancreatitis-vs-NoPancreatitis
7.235600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.974800E-01
Normal-vs-N1
8.235600E-01
N0-vs-N1
4.464200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.890800E-01
Normal-vs-TP53-NonMutant
8.992200E-01
TP53-Mutant-vs-TP53-NonMutant
3.762800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
